Fagron NV
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 4A5.F | DMP.F | 08HH.F | FREDUN.BO | PBH | DERM | |
|---|---|---|---|---|---|---|
| Market cap | 1.76B | 1.93B | 5.17B | 25.51B | 2.52B | 133.50M |
| P/E (TTM) | 19.2 | 14.1 | 11.4 | 54.2 | 14.9 | — |
| Forward P/E | — | 13.1 | — | — | 10.4 | -78.8 |
| Price/book | 3.0 | 3.6 | 0.8 | 8.8 | 1.3 | 4.1 |
| Dividend yield | 1.72% | 2.26% | 2.64% | 0.02% | — | — |
| 1-year change | +15.02% | +17.38% | −23.80% | +192.50% | −13.17% | −48.53% |
| Today | +2.57% | +1.17% | +1.79% | −1.07% | +7.55% | +1.94% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All 4A5.F news ›BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of…
Fagron NV (ARSUF) Q3 2026 Sales/ Trading Statement Call - Slideshow
(OTCMKTS:ARSUF) 2026-10-09 Seeking Alpha The following slide deck was published by Fagron NV in conjunction with this event.
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- pluang.com2
- seekingalpha.com2
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.